Creekmur Asset Management LLC Buys New Stake in HCA Healthcare, Inc. (NYSE:HCA)

Creekmur Asset Management LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 2,503 shares of the company's stock, valued at approximately $865,000.

Several other large investors have also recently made changes to their positions in the company. Sanders Capital LLC raised its position in shares of HCA Healthcare by 1.0% during the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after buying an additional 116,826 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock valued at $1,159,882,000 after purchasing an additional 50,321 shares during the last quarter. Capital World Investors raised its holdings in HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after buying an additional 19,121 shares during the period. Norges Bank bought a new position in HCA Healthcare during the fourth quarter valued at $840,286,000. Finally, Northern Trust Corp lifted its holdings in shares of HCA Healthcare by 12.4% in the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company's stock worth $605,694,000 after acquiring an additional 223,248 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.30% of the company's stock.

HCA Healthcare Stock Down 0.5%

Shares of NYSE:HCA traded down $1.69 during trading on Friday, reaching $360.91. The stock had a trading volume of 1,029,847 shares, compared to its average volume of 1,452,207. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The firm's 50-day simple moving average is $376.24 and its 200 day simple moving average is $343.58. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $86.82 billion, a P/E ratio of 16.05, a PEG ratio of 1.27 and a beta of 1.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same period last year, the business posted $5.36 earnings per share. The firm's revenue was up 5.7% compared to the same quarter last year. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.80%. The ex-dividend date was Monday, June 16th. HCA Healthcare's payout ratio is 12.81%.

Wall Street Analyst Weigh In

HCA has been the subject of several recent analyst reports. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Guggenheim began coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Bank of America cut shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a research report on Wednesday. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and set a $404.00 price target (up previously from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Eight research analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $399.21.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.